1. X
  2. Techcyte
Log inSign up
Techcyte
252 posts
Techcyte profile banner
user avatar

Techcyte

@techcyte
The Anatomic & Clinical Pathology AI Platform
Orem, UT
techcyte.com
Joined March 2016
314
Following
177
Followers
RepliesRepliesMediaMedia
  • user avatar
    Techcyte
    @techcyte
    2h
    Techcyte and Conflux are bringing AI-native reporting into Fusion. Allowing pathologists to dictate, use natural-language instructions, apply familiar templates and shortcuts, and complete structured reporting workflows without leaving the case. na2.hubs.ly/H076_Wz0
    Image
  • user avatar
    Techcyte
    @techcyte
    Aug 6
    Cytolab has moved its cervical cytology screening to a digital, AI-assisted workflow with Techcyte SureView®. Learn how Cytolab, with support from Waters Advanced Diagnostics, has made SureView part of its daily routine since January 2026: na2.hubs.ly/H06-b6Y0
    Image
  • user avatar
    Techcyte
    @techcyte
    Aug 4
    Digital pathology is about more than AI and digitizing slides. In her latest blog, Dr. Tiffany Chen shares why workforce flexibility has become one of the biggest drivers of digital pathology adoption. Read the blog: na2.hubs.ly/H06-8Zm0
    Image
  • user avatar
    Techcyte
    @techcyte
    Aug 3
    Several parasitology laboratory leaders familiar with Techcyte joined the Journal of Clinical Microbiology’s Editors in Conversation podcast to discuss the Cyclospora outbreak and how their laboratories are responding to increased testing volumes.
  • user avatar
    Techcyte
    @techcyte
    Jul 30
    When Cyclospora testing surged, Cleveland Clinic’s laboratory had to adapt. This article offers a look at the people, processes, and AI technology that are helping the team manage an extraordinary increase in testing volume. Read the full story:
    Image
    Cleveland Clinic scales lab as cyclospora tests jump from 1-2 daily to 400
    From beckershospitalreview.com

Log in or sign up for X

See what’s happening and join the conversation

Continue with phone
or
Log in with username or email
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Advertisement
Advertisement